Do serum cholesterol values and DST results comprise independent risk factors for suicide?

The Neurobiological Basis of Suicide

Volumn , Issue , 2012, Pages 125-138

  Coryell, William ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945155391     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12215     Document Type: Chapter

References (103)

1. Bunney, W. E., Jr. and Fawcett, J. A. 1965. Possibility of a biochemical test for suicidal potential: An analysis of endocrine findings prior to three suicides. Arch Gen Psychiatry 13:232-239.
2. Bunney, W. E., Jr., Fawcett, J. A., Davis, J. M., and Gifford, S. 1969. Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry 21:138-150.
3. Krieger, G. 1970. Biochemical predictors of suicide. Dis Nerv Syst 31:478-482.
4. Ostroff, R., Giller, E., Bonese, K., Ebersole, E., Harkness, L., and Mason, J. 1982. Neuroendocrine risk factors of suicidal behavior. Am J Psychiatry 139:1323-1325.
5. Dorovini-Zis, K. and Zis, A. P. 1987. Increased adrenal weight in victims of violent suicide. Am J Psychiatry 144:1214-1225.
6. Dumser, T., Barocka, A., and Schubert, E. 1998. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol 19:72-76.
7. Szigethy, E., Conwell, Y., Forbes, N. T., Cox, C., and Caine, E. D. 1994. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry 36:374-380.
8. Hoch-Ligeti, C. 1966. Adrenal cholesterol concentration in cases of suicide. Br J Exp Pathol 47:594-598.
9. Willenberg, H. S., Bornstein, S. R., Dumser, T. et al. 1998. Morphological changes in adrenals from victims of suicide in relation to altered apoptosis. Endocr Res 24:963-967.
10. Arato, M., Banki, C. M., Bissette, G., and Nemeroff, C. B. 1989. Elevated CSF CRF in suicide victims. Biol Psychiatry 25:355-359.
11. Merali, Z., Du, L., Hrdina, P. et al. 2004. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor sub-units in frontal cortical brain region. J Neurosci 24:1478-1485.
12. Austin, M. C., Janosky, J. E., and Murphy, H. A. 2003. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed sui-cide men. Mol Psychiatry 8:324-332.
13. Merali, Z., Kent, P., Du, L. et al. 2006. Corticotropin-releasing hormone, arginine vaso-pressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry 59:594-602.
14. Nemeroff, C. B., Owens, M. J., Bissette, G., Andorn, A. C., and Stanley, M. 1988. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide vic-tims. Arch Gen Psychiatry 45:577-579.
15. Hucks, D., Lowther, S., Crompton, M. R., Katona, C. L., and Horton, R. W. 1997. Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berl) 134:174-178.
16. Charlton, B., Cheetham, S. C., Horton, R. W., Kataona, C. L. E., Pormptom, M. R., and Ferrier, I. N. 1988. Corticotropin-releasing-factor immunoreactivity in post-mortem brain from patients with depressed suicides. Psychopharmacology (Berl) 2:13-18.
17. Traskman-Bendz, L., Alling, C., Oreland, L., Regnell, G., Vinge, E., and Ohman, R. 1992. Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol 12:21S-26S.
18. Black, D. W., Monahan, P. O., and Winokur, G. 2002. The relationship between DST results and suicidal behavior. Ann Clin Psychiatry 14:83-88.
19. Coryell, W. and Schlesser, M. 2001. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748-753.
20. Jokinen, J., Carlborg, A., Martensson, B., Forslund, K., Nordstrom, A. L., and Nordstrom, P. 2007. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 150:297-303.
21. Yerevanian, B. I., Feusner, J. D., Koek, R. J., and Mintz, J. 2004. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 83:103-108.
22. Coryell, W., Young, E., and Carroll, B. 2006. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res 142:99-104.
23. Carroll, B. J., Greden, J. F., and Feinberg, M. 1980. Suicide, neuroendocrine dys-function and CSF 5-HIAA concentrations in depression. Recent advances in Neuropsychopharmacology, Proceedings of 12th CINP Congress, ed. B. Angrist, Pergamon Press, Oxford, U.K.
24. Roy, A., Agren, H., Picker, D., Linnoila, M., Doran, A. R., Cutlor, N. R., and Paul, S. M. 1986. Reduced concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behav-ior and dexamethasone nonsuppression. Am J Psych 143:1539-1545.
25. Coryell, W. and Schlesser, M. A. 1981. Suicide and the dexamethasone suppression test in unipolar depression. Am J Psych 138:1120-1121.
26. Roza, R., Milanes, F., Reisch, J., Slater, V., and Garrigo, L. 1988. The DST and suicide among depressed alcoholic patients. Am J Psych 145:266-276.
27. Mann, J. J. and Currier, D. 2007. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11:3-16.
28. Norman, W. H., Brown, W. A., Miller, I. W., Keitner, G. I., and Overholser, J. C. 1990. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand 81:120-125.
29. Coryell, W. 1990. DST abnormality as a predictor of course in major depression. J Affect Disord 19:163-169.
30. Roy, A. 1992. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 32:812-816.
31. Westrin, A. and Nimeus, A. 2003. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters. Eur Psychiatry 18:166-171.
32. Coryell, W. and Young, E. A. 2005. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 66:412-417.
33. Coryell, W., Smith, R., Cook, B., Moucharafieh, S., Dunner, F., and House, D. 1983. Serial dexamethasone suppression test results during antidepressant therapy: Relationship to diagnosis and clinical change. Psychiatry Res 10:165-174.
34. Coryell, W. and Schlesser, M. A. 1983. Dexamethasone suppression test response in major depression: Stability across hospitalizations. Psychiatry Res 8:179-189.
35. Coryell, W., Turner, R. D., and Sherman, A. 1987. Desipramine plasma levels and clinical response: Evidence for a curvilinear relationship. J Clin Psychopharmacol 7:138-142.
36. Muldoon, M. F., Manuck, S. B., and Matthews, K. A. 1990. Lowering cholesterol con-centrations and mortality: A quantitative review of primary prevention trials. Br Med J 301:309-314.
37. Boscarino, J. A., Erlich, P. M., and Hoffman, S. N. 2009. Low serum cholesterol and external-cause mortality: Potential implications for research and surveillance. J Psychiatr Res 43:848-854.
38. Chen, Z., Peto, R., Collins, R., Macmahon, S., Lu, J., and Li, W. 1991. Serum choles-terol concentration and coronary heart disease in population with low cholesterol con-centrations. Br Med J 303:276-282.
39. Ellison, L. F. and Morrison, H. I. 2001. Low serum cholesterol concentration and risk of suicide. Epidemiology 12:168-172.
40. Lindberg, G., Rastam, L., Gullberg, B., and Eklund, G. A. 1992. Low serum choles-terol concentration and short term mortality from injuries in men and women. Br Med J 305:277-279.
41. Neaton, J. D., Blackburn, H., Jacobs, D. et al. 1992. Serum cholesterol level and mortal-ity findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 152:1490-1500.
42. Partonen, T., Haukka, J., Virtamo, J., Taylor, P. R., and Lonnqvist, J. 1999. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 175:259-262.
43. Tamosiunas, A., Reklaitiene, R., Radisauskas, R., and Jureniene, K. 2005. Prognosis of risk factors and trends in mortality from external causes among middle-aged men in Lithuania. Scand J Public Health 33:190-196.
44. Zureik, M., Courbon, D., and Ducimetiere, P. 1996. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. Br Med J 313:649-651.
45. Smith, G. D., Shipley, M. J., Marmot, M. G., and Rose, G. 1992. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 267:70-76.
46. Iribarren, C., Reed, D. M., Wergowske, G., Burchfiel, C. M., and Dwyer, J. H. 1995. Serum cholesterol level and mortality due to suicide and trauma in the Honolulu Heart Program. Arch Intern Med 155:695-700.
47. Tanskanen, A., Vartiainen, E., Tuomilehto, J., Viinamaki, H., Lehtonen, J., and Puska, P. 2000. High serum cholesterol and risk of suicide. Am J Psychiatry 157:648-650.
48. Atmaca, M., Kuloglu, M., Tezcan, E., and Ustundag, B. 2003. Serum leptin and choles-terol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand 108:208-214.
49. Favaro, A., Caregaro, L., Di Pascoli, L., Brambilla, F., and Santonastaso, P. 2004. Total serum cholesterol and suicidality in anorexia nervosa. Psychosom Med 66:548-552.
50. Fiedorowicz, J. G. and Coryell, W. H. 2007. Cholesterol and suicide attempts: A pro-spective study of depressed inpatients. Psychiatry Res 152:11-20.
51. Garland, M., Hickey, D., Corvin, A. et al. 2000. Total serum cholesterol in relation to psychological correlates in parasuicide. Br J Psychiatry 177:77-83.
52. Guillem, E., Pelissolo, A., Notides, C., and Lepine, J. P. 2002. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Res 112:83-88.
53. Kim, Y. K., Lee, H. J., Kim, J. Y., Yoon, D. K., Choi, S. H., and Lee, M. S. 2002. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand 105:141-148.
54. Kim, Y. K. and Myint, A. M. 2004. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81:161-166.
55. Lee, H. J. and Kim, Y. K. 2003. Serum lipid levels and suicide attempts. Acta Psychiatr Scand 108:215-221.
56. Marcinko, D., Marcinko, V., Karlovic, D. et al. 2008. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:193-196.
57. Marcinko, D., Pivac, N., Martinac, M., Jakovljevic, M., Mihaljevic-Peles, A., and Muck-Seler, D. 2007. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis. Psychiatry Res 150:105-108.
58. Marcinko, D., Popovic-Knapic, V., Franic, T. et al. 2008. Association of cholesterol and socio-demographic parameters with suicidality in the male patients with schizophrenia. Psychiatr Danub 20:390-395.
59. Modai, I., Valevski, A., Dror, S., and Weizman, A. 1994. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J Clin Psychiatry 55:252-254.
60. Ozer, O. A., Kutanis, R., Agargun, M. Y. et al. 2004. Serum lipid levels, suicidality, and panic disorder. Compr Psychiatry 45:95-98.
61. Plana, T., Gracia, R., Mendez, I., Pintor, L., Lazaro, L., and Castro-Fornieles, J. 2010. Total serum cholesterol levels and suicide attempts in child and adolescent psychiatric inpatients. Eur Child Adolesc Psychiatry 19:615-619.
62. Sarchiapone, M., Camardese, G., Roy, A. et al. 2001. Cholesterol and serotonin indices in depressed and suicidal patients. J Affect Disord 62:217-219.
63. Sullivan, P. F., Joyce, P. R., Bulik, C. M., Mulder, R. T., and Oakley-Browne, M. 1994. Total cholesterol and suicidality in depression. Biol Psychiatry 36:472-477.
64. Vuksan-Cusa, B., Marcinko, D., Nad, S., and Jakovljevic, M. 2009. Differences in cho-lesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 33:109-112.
65. Bocchetta, A., Chillotti, C., Carboni, G., Oi, A., Ponti, M., and Del Zompo, M. 2001. Association of personal and familial suicide risk with low serum cholesterol concentra-tion in male lithium patients. Acta Psychiatr Scand 104:37-41.
66. Golier, J. A., Marzuk, P. M., Leon, A. C., Weiner, C., and Tardiff, K. 1995. Low serum cholesterol level and attempted suicide. Am J Psychiatry 152:419-423.
67. Almeida-Montes, L. G., Valles-Sanchez, V., Moreno-Aguilar, J. et al. 2000. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. J Psychiatry Neurosci 25:371-377.
68. Apter, A., Laufer, N., Bar-Sever, M., Har-Even, D., Ofek, H., and Weizman, A. 1999. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in ado-lescent psychiatric inpatients. Biol Psychiatry 46:532-541.
69. Deisenhammer, E. A., Kramer-Reinstadler, K., Liensberger, D., Kemmler, G., Hinterhuber, H., and Fleischhacker, W. W. 2004. No evidence for an association between serum cho-lesterol and the course of depression and suicidality. Psychiatry Res 121:253-261.
70. Huang, T. and Wu, S. 2000. Serum cholesterol levels in paranoid and non-paranoid schizophrenia associated with physical violence or suicide attempts in Taiwanese. Psychiatry Res 96:175-178.
71. Huang, T. L. 2005. Serum lipid profiles in major depression with clinical subtypes, sui-cide attempts and episodes. J Affect Disord 86:75-79.
72. Papassotiropoulos, A., Hawellek, B., Frahnert, C., Rao, G. S., and Rao, M. L. 1999. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 32:1-4.
73. Perez-Rodriguez, M. M., Baca-Garcia, E., Diaz-Sastre, C. et al. 2008. Low serum cho-lesterol may be associated with suicide attempt history. J Clin Psychiatry 69:1920-1927.
74. Roy, A., Gonzalez, B., Marcus, A., and Berman, J. 2001. Serum cholesterol, suicidal behavior and impulsivity in cocaine-dependent patients. Psychiatry Res 101:243-247.
75. Alvarez, J. C., Cremniter, D., Gluck, N. et al. 2000. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 95:103-108.
76. Atmaca, M., Kuloglu, M., Tezcan, E., and Ustundag, B. 2008. Serum leptin and choles-terol values in violent and non-violent suicide attempters. Psychiatry Res 158:87-91.
77. Gallerani, M., Manfredini, R., Caracciolo, S., Scapoli, C., Molinari, S., and Fersini, C. 1995. Serum cholesterol concentrations in parasuicide. Br Med J 310:1632-1636.
78. Tripodianakis, J., Markianos, M., Sarantidis, D., and Agouridaki, M. 2002. Biogenic amine turnover and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci 252:38-43.
79. Lalovic, A., Levy, E., Luheshi, G. et al. 2007. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 10:159-166.
80. Repo-Tiihonen, E., Halonen, P., Tiihonen, J., and Virkkunen, M. 2002. Total serum cho-lesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disor-der. Eur Arch Psychiatry Clin Neurosci 252:8-11.
81. Maes, M., Scharpe, S., D’hondt, P. et al. 1996. Biochemical, metabolic and immune correlates of seasonal variation in violent suicide: A chronoepidemiologic study. Eur Psychiatry 11:21-33.
82. Edgar, P. F., Hooper, A. J., Poa, N. R., and Burnett, J. R. 2007. Violent behavior associ-ated with hypocholesterolemia due to a novel APOB gene mutation. Mol Psychiatry 12:258-263; 221.
83. Lalovic, A., Merkens, L., Russell, L. et al. 2004. Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers. Am J Psychiatry 161:2123-2126.
84. Golomb, B. A. 1998. Cholesterol and violence: Is there a connection? Ann Intern Med 128:478-487.
85. Golomb, B. A., Stattin, H., and Mednick, S. 2000. Low cholesterol and violent crime. J Psychiatr Res 34:301-309.
86. Asellus, P., Nordstrom, P., and Jokinen, J. 2010. Cholesterol and CSF 5-HIAA in attempted suicide. J Affect Disord 125:388-392.
87. Kaplan, J. R., Shively, C. A., Fontenot, M. B. et al. 1994. Demonstration of an asso-ciation among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 56:479-484.
88. Engstrom, G., Alsen, M., Regnell, G., and Traskman-Bendz, L. 1995. Serum lipids in suicide attempters. Suicide Life Threat Behav 25:393-400.
89. Hibbeln, J. R., Umhau, J. C., George, D. T., Shoaf, S. E., Linnoila, M., and Salem, N., Jr. 2000. Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotrans-mitter metabolites: Implications for the biophysical role of highly unsaturated fatty acids. Am J Clin Nutr 71:331S-338S.
90. Ringo, D. L., Lindley, S. E., Faull, K. F., and Faustman, W. O. 1994. Cholesterol and serotonin: Seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol Psychiatry 35:957-959.
91. Delva, N. J., Matthews, D. R., and Cowen, P. J. 1996. Brain serotonin (5-HT) neuroendo-crine function in patients taking cholesterol-lowering drugs. Biol Psychiatry 39:100-106.
92. Steegmans, P. H., Fekkes, D., Hoes, A. W., Bak, A. A., Van Der Does, E., and Grobbee, D. E. 1996. Low serum cholesterol concentration and serotonin metabolism in men. Br Med J 312:221.
93. Muldoon, M. F., Kaplan, J. R., Manuck, S. B., and Mann, J. J. 1992. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry 31:739-742.
94. Papakostas, G. I., Petersen, T., Mischoulon, D. et al. 2003. Serum cholesterol and sero-tonergic function in major depressive disorder. Psychiatry Res 118:137-145.
95. Terao, T., Nakamura, J., Yoshimura, R. et al. 2000. Relationship between serum choles-terol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res 96:167-173.
96. Vevera, J., Fisar, Z., Kvasnicka, T. et al. 2005. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 133:197-203.
97. Kaplan, J. R., Manuck, S. B., and Shively, C. 1991. The effects of fat and cholesterol on social behavior in monkeys. Psychosom Med 53:634-642.
98. Fawcett, J., Busch, K. A., Jacobs, D., Kravitz, H. M., and Fogg, L. 1997. Suicide: A four-pathway clinical-biochemical model. Ann N Y Acad Sci 836:288-301.
99. Coryell, W. and Schlesser, M. 2007. Combined biological tests for suicide prediction. Psychiatry Res 150:187-191.
100. Jokinen, J., Nordstrom, A. L., and Nordstrom, P. 2009. CSF 5-HIAA and DST non-suppression-orthogonal biologic risk factors for suicide in male mood disorder inpa-tients. Psychiatry Res 165:96-102.
101. Porter, R. J., Gallagher, P., Watson, S., and Young, A. H. 2004. Corticosteroid-serotonin interactions in depression: A review of the human evidence. Psychopharmacology (Berl) 173:1-17.
102. Jokinen, J., Nordstrom, A. L., and Nordstrom, P. 2008. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord 106:145-152.
103. Coryell, W., Fiedorowicz, J., Zimmerman, M., and Young, E. 2008. HPA-axis hyperactivity and mortality in psychotic depressive disorder: Preliminary findings. Psychoneuroendocrinology 33:654-658.